Why Eli Lilly Was Such a Healthy Stock Today
While additional drugs in the same class are sure to earn FDA approval in the coming years, Eli Lilly is well positioned in ...
Trade group sues FDA over ending Mounjaro/Zepbound shortage
A trade organization representing compounding pharmacies that make unbranded versions of the weight loss drugs Mounjaro and ...
TipRanks on MSN7h
LLY, NVS, or ISRG: Which Healthcare Stock Scores Wall Street’s “Strong Buy” Rating?
The COVID-19 pandemic made the world realize the importance of investing in healthcare infrastructure and developing ...
WeightWatchers to offer compounded version of Novo Nordisk's weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
Ibj.com11h
Lilly weight-loss drug copycat makers sue FDA for taking drugs off shortage list
The plaintiffs allege that the shortage of Lilly’s drugs isn’t actually over, and that the agency’s decision deprives ...
WeightWatchers to offer compounded version of Wegovy weight-loss drug
WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...
JD Supra12h
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
FiercePharma13h
Compounders sue FDA for removing Eli Lilly's tirzepatide from shortage list
With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...
WTAQ14h
WeightWatchers adds compounded version of Novo’s obesity drug to weight-loss program
WeightWatchers said on Tuesday it would offer compounded form of Novo Nordisk's popular obesity drug Wegovy as part of its ...
Mounjaro will soon be available as a weight loss treatment on the NHS - here's what that means for patients
Now that Mounjaro has been authorised for use on the NHS, it will be key that access to specialist weight loss services is ...
PharmiWeb15h
Lexaria Updates Current GLP-1 Market
KELOWNA, BC / ACCESSWIRE / October 8, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery technology, provides an update on ...